help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 19, 2004
Endocrinology, doi:10.1210/en.2004-0059
A more recent version of this article appeared on July 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/7/3224    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verty, A. N. A.
Right arrow Articles by Mallet, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verty, A. N. A.
Right arrow Articles by Mallet, P. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH

Submitted on January 19, 2004
Accepted on March 9, 2004

Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake

A. N. A. Verty, J. R. McFarlane, I. S. McGregor, and P. E. Mallet*

School of Psychologyand School of Biological, Biomedical & Molecular Science, University of New England, Armidale, NSW 2351, Australia. School of Psychology, University of Sydney, NSW 2006, Australia.

* To whom correspondence should be addressed. E-mail: paul.mallet{at}une.edu.au.

Melanocortin receptor 4 (MCR4) and CB1 cannabinoid receptors independently modulate food intake. Although an interaction between cannabinoid and melanocortin systems has been found in recovery from hemorrhagic shock, the interaction between these systems in modulating food intake has not yet been examined. The present study had two primary purposes: (1) to examine whether the cannabinoid and melanocortin systems act independently or synergistically in suppressing food intake and (2) to determine the relative position of the CB1 receptors in the chain of control of food intake in relation to the melanocortin system. Rats were habituated to the test environment and injection procedure, and then received intracerebroventicular (ICV) injections of various combinations of the MCR4 receptor antagonist JKC-363, the CB1 receptor agonist {Delta}9-tetrahydrocannabinol (THC), the MCR4 receptor agonist {alpha}-MSH, or the cannabinoid CB1 receptor antagonist SR 141716. Food intake and locomotor activity were then recorded for 120 min. When administrated alone, SR 141716 and {alpha}-MSH dose-dependently attenuated baseline feeding, while sub-anorectic doses of SR 141716 and {alpha}-MSH synergistically attenuated baseline feeding when combined. THC-induced feeding was not blocked by {alpha}-MSH, while SR 141716 dose-dependently attenuated JKC-363-induced feeding. Locomotor activity was not significantly gaffected by any drug treatment, suggesting that the observed effects on feeding were not due to a non-specific reduction in motivated behavior. These findings reveal a synergistic interaction between cannabinoid and melanocortin systems in feeding behavior. These results further suggest that CB1 receptors are located downstream from melanocortin receptors, and CB1 receptor signaling is necessary to prevent the melanocortin system from altering food intake.


Key words: Cannabinoids • Melanocortin • Feeding • Rat • Antagonist




This article has been cited by other articles:


Home page
DiabetesHome page
C. Doyon, R. G. Denis, E.-D. Baraboi, P. Samson, J. Lalonde, Y. Deshaies, and D. Richard
Effects of Rimonabant (SR141716) on Fasting-Induced Hypothalamic-Pituitary-Adrenal Axis and Neuronal Activation in Lean and Obese Zucker Rats
Diabetes, December 1, 2006; 55(12): 3403 - 3410.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. M. Gadde and D. B. Allison
Cannabinoid-1 Receptor Antagonist, Rimonabant, for Management of Obesity and Related Risks
Circulation, August 29, 2006; 114(9): 974 - 984.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Endocr. Rev., February 1, 2006; 27(1): 73 - 100.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Stanley, K. Wynne, B. McGowan, and S. Bloom
Hormonal Regulation of Food Intake
Physiol Rev, October 1, 2005; 85(4): 1131 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
I. S. McGREGOR, K. D. B. DAM, P. E. MALLET, and J. E. GALLATE
{Delta}9-THC REINSTATES BEER- AND SUCROSE-SEEKING BEHAVIOUR IN ABSTINENT RATS: COMPARISON WITH MIDAZOLAM, FOOD DEPRIVATION AND PREDATOR ODOUR
Alcohol Alcohol., January 1, 2005; 40(1): 35 - 45.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society